Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Dec;66(3):599–605.

Relationship of macrophages to defective delayed-type hypersensitivity in B6/lpr mice.

H Okuyama, K Yamamoto, T Matsunaga, S Kobayashi, Y Hashimoto
PMCID: PMC1542477  PMID: 3552337

Abstract

These experiments were undertaken to clarify whether or not suppressor macrophages contribute to deficiency of delayed-type hypersensitivity induced by BCG CW immunization in B6/lpr mice. Addition of indomethacin in vitro did not increase MIF production by immunized lpr lymph node cells. Adherent cells in lymph node cell suspensions from lpr mice did not interfere with MIF production by nonadherent lymph node cells from immunized B6 mice. On the other hand, MIF production by nonadherent lymph node cells from immunized B6/lpr mice was not restored even if they were cultured with adherent lymph node cells from immunized B6 mice. In addition, macrophages from nonimmunized B6/lpr mice showed normal reactivity to MIF when lymphocytes coexisting with the macrophages in large proportions were depleted from PEC. These results suggest that macrophages make no contribution to the deficiency of DTH expression of B6/lpr mice.

Full text

PDF
599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman A., Theofilopoulos A. N., Weiner R., Katz D. H., Dixon F. J. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med. 1981 Sep 1;154(3):791–808. doi: 10.1084/jem.154.3.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dauphinée M. J., Kipper S. B., Wofsy D., Talal N. Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol. 1981 Dec;127(6):2483–2487. [PubMed] [Google Scholar]
  3. Davignon J. L., Budd R. C., Ceredig R., Piguet P. F., MacDonald H. R., Cerottini J. C., Vassalli P., Izui S. Functional analysis of T cell subsets from mice bearing the lpr gene. J Immunol. 1985 Oct;135(4):2423–2428. [PubMed] [Google Scholar]
  4. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  5. Fischbach M. Defective T cell response to presented antigen in autoimmune mice. J Immunol. 1984 Nov;133(5):2365–2368. [PubMed] [Google Scholar]
  6. Gordon D., Bray M. A., Morley J. Control of lymphokine secretion by prostaglandins. Nature. 1976 Jul 29;262(5567):401–402. doi: 10.1038/262401a0. [DOI] [PubMed] [Google Scholar]
  7. Jones F. S., Pisetsky D. S., Kurlander R. J. Defects in mononuclear phagocytic system (MPS) function in autoimmune MRL-lpr/lpr mice. Clin Immunol Immunopathol. 1985 Jul;36(1):30–39. doi: 10.1016/0090-1229(85)90036-4. [DOI] [PubMed] [Google Scholar]
  8. Kato K., Yamamoto K. I., Kakinuma M., Ishihara C., Azuma I. Suppression of BCG cell wall induced delayed-type hypersensitivity by BCG pre-treatment. I. Induction of adherent suppressor cells by live BCG injection and their characterization. Immunology. 1981 Feb;42(2):259–266. [PMC free article] [PubMed] [Google Scholar]
  9. Kato K., Yamamoto K. Involvement of prostaglandin E1 in delayed-type hypersensitivity suppression induced with live Mycobacterium bovis BCG. Infect Immun. 1982 Apr;36(1):426–429. doi: 10.1128/iai.36.1.426-429.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kelley V. E., Roths J. B. Increase in macrophage Ia expression in autoimmune mice: role of the Ipr gene. J Immunol. 1982 Sep;129(3):923–925. [PubMed] [Google Scholar]
  11. Lu C. Y., Unanue E. R. Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoricidal activity in MRL-lpr mice. Clin Immunol Immunopathol. 1982 Nov;25(2):213–222. doi: 10.1016/0090-1229(82)90184-2. [DOI] [PubMed] [Google Scholar]
  12. Metzger Z., Hoffeld J. T., Oppenheim J. J. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol. 1980 Feb;124(2):983–988. [PubMed] [Google Scholar]
  13. Okuyama H., Yamamoto K., Matsunaga T., Kobayashi S., Tashiro A. Analysis of defective delayed-type hypersensitivity in autoimmune mice bearing lpr gene. Clin Exp Immunol. 1986 Jan;63(1):87–94. [PMC free article] [PubMed] [Google Scholar]
  14. Petit J. C., Richard G., Burghoffer B., Daguet G. L. Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins. Infect Immun. 1985 Aug;49(2):383–388. doi: 10.1128/iai.49.2.383-388.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Russell P. J., Steinberg A. D. Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunopathol. 1983 Jun;27(3):387–402. doi: 10.1016/0090-1229(83)90091-0. [DOI] [PubMed] [Google Scholar]
  16. Scott C. F., Jr, Tsurufuji M., Lu C. Y., Finberg R., Sy M. S. Comparison of antigen-specific T cell responses in autoimmune MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. J Immunol. 1984 Feb;132(2):633–639. [PubMed] [Google Scholar]
  17. Shear H. L., Wofsy D., Talal N. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Clin Immunol Immunopathol. 1983 Mar;26(3):361–369. doi: 10.1016/0090-1229(83)90120-4. [DOI] [PubMed] [Google Scholar]
  18. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  19. Webb D. R., Jr, Jamieson T. Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol. 1976 Jun 1;24(1):45–57. doi: 10.1016/0008-8749(76)90130-1. [DOI] [PubMed] [Google Scholar]
  20. Wofsy D., Murphy E. D., Roths J. B., Dauphinée M. J., Kipper S. B., Talal N. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med. 1981 Nov 1;154(5):1671–1680. doi: 10.1084/jem.154.5.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yamamoto K., Karinuma M. Genetic control of granuloma response to oil-associated BCG cell wall vaccine in mice. Microbiol Immunol. 1978;22(6):335–348. doi: 10.1111/j.1348-0421.1978.tb00378.x. [DOI] [PubMed] [Google Scholar]
  22. van der Woude F. J., van der Giessen M., Kallenberg C. G., Ouwehand W., Beekhuis H., Beelen J. M., van Son W. J., Hoedemaeker P. J., van der Hem G. K., The T. H. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin Exp Immunol. 1984 Mar;55(3):473–480. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES